Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002837069 | SCV003616799 | uncertain significance | Inborn genetic diseases | 2022-05-16 | criteria provided, single submitter | clinical testing | The c.4791G>T (p.E1597D) alteration is located in exon 41 (coding exon 41) of the BRWD3 gene. This alteration results from a G to T substitution at nucleotide position 4791, causing the glutamic acid (E) at amino acid position 1597 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |